PG-760564
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PG-760564, covering 2011-09-08 to 2011-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days [Phase 1]